The gastrointestinal devices market size has grown strongly in recent years. It will grow from $11.7 billion in 2025 to $12.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal disorders, expansion of hospital gastroenterology departments, technological improvements in endoscopic imaging, increasing screening programs, availability of advanced gi devices.
The gastrointestinal devices market size is expected to see strong growth in the next few years. It will grow to $17.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted gi diagnostics, rising investments in advanced endoscopy centers, expansion of outpatient gi procedures, growing demand for single-use gi devices, increasing focus on patient safety and efficiency. Major trends in the forecast period include increasing adoption of advanced gi endoscopic procedures, rising use of capsule endoscopy systems, growing demand for minimally invasive gi treatments, expansion of therapeutic endoscopy applications, enhanced focus on early disease detection tools.
The rising prevalence of gastrointestinal diseases is expected to drive growth in the gastrointestinal devices market. Gastrointestinal diseases are disorders affecting the digestive tract and related organs, causing symptoms that range from mild discomfort to severe complications. This prevalence is largely driven by aging populations, as older adults experience higher rates of digestive system disorders requiring medical intervention. Increased diagnoses create greater demand for specialized diagnostic and therapeutic devices that help healthcare providers effectively manage these conditions. For example, in July 2023, Crohn’s and Colitis Canada, a Canada-based national, volunteer-based charity, reported that by 2035, the number of inflammatory bowel disease (IBD) patients in Canada is projected to reach 470,000, up from an estimated 322,600 in 2023. This growing prevalence is therefore fueling the expansion of the gastrointestinal devices market.
Major companies operating in the gastrointestinal devices sector are strategically expanding their endoscopy solutions portfolio. This expansion involves the development and introduction of new products and services related to endoscopy, a medical procedure that utilizes an endoscope for internal examinations. For example, in January 2023, Fujifilm India Private Limited launched ClutchCutter and FlushKnife, part of a new suite of endoscopy solutions designed for therapeutic gastrointestinal applications. ClutchCutter, a rotatable forceps, combines coagulation, dissection, and incision functions, providing clinicians with versatile capabilities. It features an insulated outer edge for durability and serrated jaws for enhanced grasping capabilities. On the other hand, FlushKnife is a diathermic slitter enabling medical professionals to perform various tasks, including marking, flushing, incision, dissection, and coagulation. The product's ball-tip option enhances traction for effective tissue dissection and coagulation. This strategic focus on expanding endoscopy solutions demonstrates companies' commitment to innovation and competitiveness in the gastrointestinal devices market.
In February 2023, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, completed the acquisition of Taewoong Medical for $370 million. Following the acquisition, Taewoong's portfolio will be integrated into Olympus' therapeutic solutions division. Olympus emphasized the inclusion of Taewoong's extensive line of metallic gastrointestinal (GI) stents, utilized in minimally invasive procedures to address blockages or restrictions in the biliary tract, esophagus, colon, or duodenum caused by conditions such as cancer or digestive system issues. Taewoong Medical, based in South Korea, is a manufacturer of medical devices, including gastrointestinal metallic stents.
Major companies operating in the gastrointestinal devices market are B. Braun Melsungen AG, Olympus Corporation, Interscope Inc., Steris plc, Cook Group Incorporated, MICRO-TECH Co. Ltd., Cantel Medical Corp., CONMED Corporation, PENTAX Medical Company, Karl Storz SE & Co. KG, US Endoscopy Inc., Richard Wolf GmbH, Motus GI Holdings Inc., Congentix Medical Inc., ERBE Elektromedizin GmbH, Creo Medical Group plc, GI Dynamics Inc., Mauna Kea Technologies SA, EndoMaster Pte Ltd., Fujifilm Holdings Corporation.
North America was the largest region in the gastrointestinal devices market in 2025. Asia-Pacific was the second largest region in the gastrointestinal devices market report. The regions covered in the gastrointestinal devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the gastrointestinal devices market by increasing costs of imported endoscopes, imaging components, biopsy tools, and electronic subsystems. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported advanced gi equipment, while Asia-Pacific faces export-related cost pressures. These tariffs are increasing device acquisition costs and slowing upgrades. However, they are also encouraging domestic manufacturing and regional supply chain development for gi devices.
The gastrointestinal devices market research report is one of a series of new reports that provides gastrointestinal devices market statistics, including gastrointestinal devices industry global market size, regional shares, competitors with a gastrointestinal devices market share, detailed gastrointestinal devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal devices industry. This gastrointestinal devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastrointestinal devices encompass tools utilized for diagnosing and treating medical issues concerning the digestive system or the gastrointestinal tract.
Primary gastrointestinal device types include GI videoscopes, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopy, endoscopic ultrasound, endoscopic mucosal resection (EMR), hemostasis devices, and others. ERCP involves diagnosing and treating liver, gallbladder, bile duct, and pancreas issues. These devices are distributed through online retailing, medical stores, and brand outlets, catering to hospitals, clinics, dialysis centers, and ambulatory surgical centers.
The gastrointestinal devices market consists of sales of instruments such as gastroscope, an enteroscope, and an ultrasound endoscope. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The gastrointestinal devices market size is expected to see strong growth in the next few years. It will grow to $17.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted gi diagnostics, rising investments in advanced endoscopy centers, expansion of outpatient gi procedures, growing demand for single-use gi devices, increasing focus on patient safety and efficiency. Major trends in the forecast period include increasing adoption of advanced gi endoscopic procedures, rising use of capsule endoscopy systems, growing demand for minimally invasive gi treatments, expansion of therapeutic endoscopy applications, enhanced focus on early disease detection tools.
The rising prevalence of gastrointestinal diseases is expected to drive growth in the gastrointestinal devices market. Gastrointestinal diseases are disorders affecting the digestive tract and related organs, causing symptoms that range from mild discomfort to severe complications. This prevalence is largely driven by aging populations, as older adults experience higher rates of digestive system disorders requiring medical intervention. Increased diagnoses create greater demand for specialized diagnostic and therapeutic devices that help healthcare providers effectively manage these conditions. For example, in July 2023, Crohn’s and Colitis Canada, a Canada-based national, volunteer-based charity, reported that by 2035, the number of inflammatory bowel disease (IBD) patients in Canada is projected to reach 470,000, up from an estimated 322,600 in 2023. This growing prevalence is therefore fueling the expansion of the gastrointestinal devices market.
Major companies operating in the gastrointestinal devices sector are strategically expanding their endoscopy solutions portfolio. This expansion involves the development and introduction of new products and services related to endoscopy, a medical procedure that utilizes an endoscope for internal examinations. For example, in January 2023, Fujifilm India Private Limited launched ClutchCutter and FlushKnife, part of a new suite of endoscopy solutions designed for therapeutic gastrointestinal applications. ClutchCutter, a rotatable forceps, combines coagulation, dissection, and incision functions, providing clinicians with versatile capabilities. It features an insulated outer edge for durability and serrated jaws for enhanced grasping capabilities. On the other hand, FlushKnife is a diathermic slitter enabling medical professionals to perform various tasks, including marking, flushing, incision, dissection, and coagulation. The product's ball-tip option enhances traction for effective tissue dissection and coagulation. This strategic focus on expanding endoscopy solutions demonstrates companies' commitment to innovation and competitiveness in the gastrointestinal devices market.
In February 2023, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, completed the acquisition of Taewoong Medical for $370 million. Following the acquisition, Taewoong's portfolio will be integrated into Olympus' therapeutic solutions division. Olympus emphasized the inclusion of Taewoong's extensive line of metallic gastrointestinal (GI) stents, utilized in minimally invasive procedures to address blockages or restrictions in the biliary tract, esophagus, colon, or duodenum caused by conditions such as cancer or digestive system issues. Taewoong Medical, based in South Korea, is a manufacturer of medical devices, including gastrointestinal metallic stents.
Major companies operating in the gastrointestinal devices market are B. Braun Melsungen AG, Olympus Corporation, Interscope Inc., Steris plc, Cook Group Incorporated, MICRO-TECH Co. Ltd., Cantel Medical Corp., CONMED Corporation, PENTAX Medical Company, Karl Storz SE & Co. KG, US Endoscopy Inc., Richard Wolf GmbH, Motus GI Holdings Inc., Congentix Medical Inc., ERBE Elektromedizin GmbH, Creo Medical Group plc, GI Dynamics Inc., Mauna Kea Technologies SA, EndoMaster Pte Ltd., Fujifilm Holdings Corporation.
North America was the largest region in the gastrointestinal devices market in 2025. Asia-Pacific was the second largest region in the gastrointestinal devices market report. The regions covered in the gastrointestinal devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the gastrointestinal devices market by increasing costs of imported endoscopes, imaging components, biopsy tools, and electronic subsystems. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported advanced gi equipment, while Asia-Pacific faces export-related cost pressures. These tariffs are increasing device acquisition costs and slowing upgrades. However, they are also encouraging domestic manufacturing and regional supply chain development for gi devices.
The gastrointestinal devices market research report is one of a series of new reports that provides gastrointestinal devices market statistics, including gastrointestinal devices industry global market size, regional shares, competitors with a gastrointestinal devices market share, detailed gastrointestinal devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal devices industry. This gastrointestinal devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastrointestinal devices encompass tools utilized for diagnosing and treating medical issues concerning the digestive system or the gastrointestinal tract.
Primary gastrointestinal device types include GI videoscopes, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopy, endoscopic ultrasound, endoscopic mucosal resection (EMR), hemostasis devices, and others. ERCP involves diagnosing and treating liver, gallbladder, bile duct, and pancreas issues. These devices are distributed through online retailing, medical stores, and brand outlets, catering to hospitals, clinics, dialysis centers, and ambulatory surgical centers.
The gastrointestinal devices market consists of sales of instruments such as gastroscope, an enteroscope, and an ultrasound endoscope. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Gastrointestinal Devices Market Characteristics
3. Gastrointestinal Devices Market Supply Chain Analysis
4. Global Gastrointestinal Devices Market Trends and Strategies
5. Gastrointestinal Devices Market Analysis of End Use Industries
7. Global Gastrointestinal Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Gastrointestinal Devices Total Addressable Market (TAM) Analysis for the Market
9. Gastrointestinal Devices Market Segmentation
10. Gastrointestinal Devices Market Regional and Country Analysis
11. Asia-Pacific Gastrointestinal Devices Market
12. China Gastrointestinal Devices Market
13. India Gastrointestinal Devices Market
14. Japan Gastrointestinal Devices Market
15. Australia Gastrointestinal Devices Market
16. Indonesia Gastrointestinal Devices Market
17. South Korea Gastrointestinal Devices Market
18. Taiwan Gastrointestinal Devices Market
19. South East Asia Gastrointestinal Devices Market
20. Western Europe Gastrointestinal Devices Market
21. UK Gastrointestinal Devices Market
22. Germany Gastrointestinal Devices Market
23. France Gastrointestinal Devices Market
24. Italy Gastrointestinal Devices Market
25. Spain Gastrointestinal Devices Market
26. Eastern Europe Gastrointestinal Devices Market
27. Russia Gastrointestinal Devices Market
28. North America Gastrointestinal Devices Market
29. USA Gastrointestinal Devices Market
30. Canada Gastrointestinal Devices Market
31. South America Gastrointestinal Devices Market
32. Brazil Gastrointestinal Devices Market
33. Middle East Gastrointestinal Devices Market
34. Africa Gastrointestinal Devices Market
36. Gastrointestinal Devices Market Competitive Landscape and Company Profiles
37. Gastrointestinal Devices Market Other Major and Innovative Companies
40. Gastrointestinal Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Gastrointestinal Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses gastrointestinal devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gastrointestinal devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: GI Videoscopes; Biopsy Devices; Endoscopic Retrograde Cholangiopancreatography Devices (ERCP); Capsule Endoscopy; Endoscopic Ultrasound; Endoscopic Mucosal Resection (EMR); Hemostasis Devices; Other Product Types2) By Sales Channel: Online Retailing; Medical Stores And Brand Outlet
3) By End Users: Hospitals; Clinics And Dialysis Centers; Ambulatory Surgical Center
Subsegments:
1) By GI Videoscopes: Flexible Videoscopes; Rigid Videoscopes2) By Biopsy Devices: Needle Biopsy Devices; Forceps Biopsy Devices; Punch Biopsy Devices
3) By Endoscopic Retrograde Cholangiopancreatography Devices (ERCP): ERCP Cannulas; Guidewires; Balloon Sweep Devices
4) By Capsule Endoscopy: Small Intestine Capsule Endoscopes; Esophageal Capsule Endoscopes; Colonic Capsule Endoscopes
5) By Endoscopic Ultrasound: EUS Scopes; EUS-guided Fine-needle Aspiration (FNA) Devices
6) By Endoscopic Mucosal Resection (EMR): EMR Kits; EMR Suction Devices
7) By Hemostasis Devices: Mechanical Hemostasis Devices; Thermal Hemostasis Devices; Chemical Hemostasis Agents
8) By Other Product Types: Enteral Feeding Devices; Gastrostomy Tubes; Accessories For GI Devices
Companies Mentioned: B. Braun Melsungen AG; Olympus Corporation; Interscope Inc.; Steris plc; Cook Group Incorporated; MICRO-TECH Co. Ltd.; Cantel Medical Corp.; CONMED Corporation; PENTAX Medical Company; Karl Storz SE & Co. KG; US Endoscopy Inc.; Richard Wolf GmbH; Motus GI Holdings Inc.; Congentix Medical Inc.; ERBE Elektromedizin GmbH; Creo Medical Group plc; GI Dynamics Inc.; Mauna Kea Technologies SA; EndoMaster Pte Ltd.; Fujifilm Holdings Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Gastrointestinal Devices market report include:- B. Braun Melsungen AG
- Olympus Corporation
- Interscope Inc.
- Steris plc
- Cook Group Incorporated
- MICRO-TECH Co. Ltd.
- Cantel Medical Corp.
- CONMED Corporation
- PENTAX Medical Company
- Karl Storz SE & Co. KG
- US Endoscopy Inc.
- Richard Wolf GmbH
- Motus GI Holdings Inc.
- Congentix Medical Inc.
- ERBE Elektromedizin GmbH
- Creo Medical Group plc
- GI Dynamics Inc.
- Mauna Kea Technologies SA
- EndoMaster Pte Ltd.
- Fujifilm Holdings Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.69 Billion |
| Forecasted Market Value ( USD | $ 17.46 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
